SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-077437
Filing Date
2024-06-25
Accepted
2024-06-25 17:34:30
Documents
1
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3854
  Complete submission text file 0000950170-24-077437.txt   5379
Mailing Address 888 7TH AVENUE 12TH FLOOR NEW YORK NY 10106
Business Address
AGUIAR ERIC (Reporting) CIK: 0001262325 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 241070062

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)